High levels of IL8 were associated with the risk of future CHD, defined as fatal and non-fatal CHD in individuals aged 45–79 years after 6 years of follow-up in a UK population [9] whereas IL8 were not associated with incident CHD, defined as incident fatal, non-fatal MI and sudden cardiac death, in a German population below the age of 75 years after 11 years of follow-up [10]. This evidence concerns the gene CXCL8 and coronary artery disorder.